MicroGenDX Press Releases

December 14, 2021

Microbiomes in Post-Digital Rectal Exam Urine Samples Linked to Prostate Cancer Risk Featured at 2021 AUA Annual Meeting

Clinical research using MicroGenDX molecular testing highlights diagnostic applications
October 8, 2021

Dr. Karan Goswami Wins EOA Parvizi Musculoskeletal Infection Award

Dr. Karan Goswami of the Rothman Orthopaedic Institute at Thomas Jefferson University has received the prestigious Eastern Orthopaedic Association’s Parvizi Musculoskeletal Infection Award for his paper entitled “Fracture-associated Microbiome and Persistent Nonunion: Next-Generation Sequencing Reveals.” This award is given to a Resident or Fellow with one of the top papers presented at the EOA’s Annual Meeting.
September 16, 2021
MicroGenDX News

Dr. J. Curtis Nickel Urinary Microbiome Study Using MicroGenDX NGS Indicates Microbial Diversity Varies by Age and Gender

Dr. J. Curtis Nickel, with the help of MicroGenDX, has completed a study to help understand the implications of Next-Generation DNA Sequencing (NGS) in the diagnosis and treatment of Urinary Tract Infections (UTIs) and other inflammatory urological conditions.
September 10, 2021
MicroGenDX News

MicroGenDX Resolves Dispute with AdventHealth over COVID-19 Testing Services

ORLANDO, Fla., May 24, 2021 /PRNewswire/ — MicroGen Diagnostics (MicroGenDX) is pleased to announce that it has resolved a dispute with AdventHealth concerning Covid-19 testing services that were provided to AdventHealth during the height of the global pandemic in May of 2020.
September 1, 2021
MicroGenDX News

MicroGenDX Announces Acquisition of RTL Genomics to Advance Primary Research in DNA Sequencing

ORLANDO, Fla., Sep 1, 2021 /PRNewswire/ — MicroGen Diagnostics, the industry leader in providing Next-Generation DNA Sequencing (NGS) for clinical diagnostics, has acquired its RTL Genomics partner lab to expand expertise and capacity in non-clinical primary research.
Translate »
Shopping cart
There are no products in the cart!
Continue shopping